Literature DB >> 25917706

Vascular parkinsonism--characteristics, pathogenesis and treatment.

Amos D Korczyn1.   

Abstract

Parkinson disease is a primary degenerative disease of the brain, but parkinsonism can also result from a variety of vascular disorders. Vascular parkinsonism (VP) most frequently presents as lower body parkinsonism, a condition that is accompanied by the development of white matter lesions (WMLs) and lacunes in the brain. Patients with lower body parkinsonism exhibit gait impairment and go on to develop urinary incontinence, abnormal pyramidal responses and cognitive decline. However, WMLs and lacunes are also common observations among elderly individuals who do not have parkinsonism, which causes difficulty in determining the pathogenetic mechanisms that lead to VP. In addition, imaging studies suggest that many pathological and clinical features are common to VP and Binswanger disease, a type of small vessel vascular dementia. This Review summarizes current understanding of the clinical characteristics of VP, as well as knowledge gained from neuroimaging and nuclear imaging of the pathological features of VP. The lack of current treatment options, and the emergence of new therapies such as cerebrospinal fluid drainage, are also discussed. Finally, consideration is given to whether the overlap between VP and Binswanger disease means that these two disorders should be considered as part of the same disease entity.

Entities:  

Mesh:

Year:  2015        PMID: 25917706     DOI: 10.1038/nrneurol.2015.61

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  65 in total

1.  Association of gait and balance disorders with age-related white matter changes: the LADIS study.

Authors:  H Baezner; C Blahak; A Poggesi; L Pantoni; D Inzitari; H Chabriat; T Erkinjuntti; F Fazekas; J M Ferro; P Langhorne; J O'Brien; P Scheltens; M C Visser; L O Wahlund; G Waldemar; A Wallin; M G Hennerici
Journal:  Neurology       Date:  2008-03-18       Impact factor: 9.910

2.  Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system.

Authors:  F Wegner; K Strecker; J Schwarz; A Wagner; W Heinritz; F Sommerer; D R Thal; J-P Schneider; K Kendziorra; O Sabri
Journal:  J Neurol       Date:  2007-11-21       Impact factor: 4.849

3.  Vascular pathology in patients with idiopathic Parkinson's disease.

Authors:  Ivan Rektor; David Goldemund; Katerina Sheardová; Irena Rektorová; Zuzana Michálková; Michal Dufek
Journal:  Parkinsonism Relat Disord       Date:  2008-04-09       Impact factor: 4.891

4.  Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.

Authors:  K Y Tzen; C S Lu; T C Yen; S P Wey; G Ting
Journal:  J Nucl Med       Date:  2001-03       Impact factor: 10.057

5.  Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease.

Authors:  Sonia Benítez-Rivero; Víctor A Marín-Oyaga; David García-Solís; Ismael Huertas-Fernández; Francisco J García-Gómez; Silvia Jesús; María Teresa Cáceres; Fátima Carrillo; Ana M Ortiz; Manuel Carballo; Pablo Mir
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-08-20       Impact factor: 10.154

6.  The clinical features of pathologically confirmed vascular parkinsonism.

Authors:  Philip George Glass; Andrew J Lees; Aroldo Bacellar; Jan Zijlmans; Regina Katzenschlager; Laura Silveira-Moriyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-10       Impact factor: 10.154

7.  EEG findings in patients with vascular parkinsonism.

Authors:  J C Zijlmans; J W Pasman; M W Horstink; D F Stegeman; M A van't Hof; D J Poortvliet; S L Notermans; E J Jonkman
Journal:  Acta Neurol Scand       Date:  1998-10       Impact factor: 3.209

8.  Basal ganglia lacunes and parkinsonism.

Authors:  R Inzelberg; N M Bornstein; I Reider; A D Korczyn
Journal:  Neuroepidemiology       Date:  1994       Impact factor: 3.282

Review 9.  Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment.

Authors:  Gary A Rosenberg; Maria Bjerke; Anders Wallin
Journal:  Stroke       Date:  2014-04-01       Impact factor: 7.914

10.  Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs.

Authors:  Karlijn F de Laat; Anouk G W van Norden; Rob A R Gons; Inge W M van Uden; Marcel P Zwiers; Bastiaan R Bloem; Ewoud J van Dijk; Frank-Erik de Leeuw
Journal:  Stroke       Date:  2012-08-02       Impact factor: 7.914

View more
  40 in total

Review 1.  The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.

Authors:  Branislav Veselý; Angelo Antonini; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2015-10-19       Impact factor: 3.575

Review 2.  An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.

Authors:  Ivan Rektor; Nicolaas I Bohnen; Amos D Korczyn; Viktoria Gryb; Hrishikesh Kumar; Milica G Kramberger; Frank-Erik de Leeuw; Zvezdan Pirtošek; Irena Rektorová; Ilana Schlesinger; Jaroslaw Slawek; Peter Valkovič; Branislav Veselý
Journal:  Parkinsonism Relat Disord       Date:  2017-12-29       Impact factor: 4.891

Review 3.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 4.  Differentiation of atypical Parkinson syndromes.

Authors:  Günter U Höglinger; Jan Kassubek; Ilona Csoti; Reinhard Ehret; Heinz Herbst; Ingmar Wellach; Jürgen Winkler; Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2017-02-27       Impact factor: 3.575

5.  MRI volumetric morphometry in vascular parkinsonism.

Authors:  Vincent Dunet; Jeremy Deverdun; Celine Charroud; Emmanuelle Le Bars; Francois Molino; Sophie Menjot de Champfleur; Florence Maury; Mahmoud Charif; Xavier Ayrignac; Pierre Labauge; Giovanni Castelnovo; Frederic Pinna; Alain Bonafe; Christian Geny; Nicolas Menjot de Champfleur
Journal:  J Neurol       Date:  2017-07-01       Impact factor: 4.849

Review 6.  Intracranial atherosclerotic disease.

Authors:  Yuan Wang; Ran Meng; Gang Liu; Catherine Cao; Fenghua Chen; Kunlin Jin; Xunming Ji; Guodong Cao
Journal:  Neurobiol Dis       Date:  2018-11-12       Impact factor: 5.996

7.  Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study.

Authors:  Hsiu-Li Lin; Hsiu-Chen Lin; Yuan-Fu Tseng; Shih-Chang Chen; Chien-Yeh Hsu
Journal:  Eur J Clin Pharmacol       Date:  2016-12-16       Impact factor: 2.953

8.  Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.

Authors:  Cristina Barbagallo; Giovanni Mostile; Gloriangela Baglieri; Flavia Giunta; Antonina Luca; Loredana Raciti; Mario Zappia; Michele Purrello; Marco Ragusa; Alessandra Nicoletti
Journal:  Cell Mol Neurobiol       Date:  2019-11-06       Impact factor: 5.046

Review 9.  Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.

Authors:  Sebastian A Lewandowski; Linda Fredriksson; Daniel A Lawrence; Ulf Eriksson
Journal:  Pharmacol Ther       Date:  2016-08-12       Impact factor: 12.310

Review 10.  Establishment and Dysfunction of the Blood-Brain Barrier.

Authors:  Zhen Zhao; Amy R Nelson; Christer Betsholtz; Berislav V Zlokovic
Journal:  Cell       Date:  2015-11-19       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.